The range of value and potential clinical implication of CA-125 regarding its predictive value in monitoring HF beyond and the correlates with other well-established HF markers (e.g. BNP or NT-ProBNP) remained largely unknown. This evidence concerns the gene NPPB and hydrops fetalis.